Stroke Journal

FEBRUARY 1, 2024

Introduction:This study evaluates the outcomes of a survivor-centric, navigator-driven, technology-enabled platform supporting survivors (SS) and care partners(CP) in post-stroke recovery. This mixed methods study utilizes focus group feedback, survey, app usage and patient-reported outcomes data.

Outcomes 40

Outcomes Stroke Strokes Quality of Life 40

GEMMS

APRIL 8, 2024

Established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) , the MIPS Program is pivotal in determining Medicare payment adjustments for healthcare practices. What is MIPS?

Medicare 52

Medicare Innovation Medicaid Patient Care 52

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

The Beat Blog

MAY 23, 2023

I learned about the complexities of health insurance – and after several years, I transitioned to the Medicare & Retirement Clinical value team where we worked to reduce the cost of United’s Medicare Advantage plans. Technology in healthcare is a double-edged sword.

Technology 52

Technology Gerontology Medicare Nursing 52

Wellnest

JUNE 19, 2023

The development has urged us to integrate the latest Artificial Intelligence with the healthcare system, including Cardiac Medicare. By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. What is Artificial Intelligence? For instance: 1.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

DAIC

JANUARY 3, 2024

With more than 500 peer-reviewed publications, the HeartFlow FFR CT Analysis remains unparalleled in precision coronary care, as supported by the ACC/AHA Chest Pain Guidelines, to improve treatment plans and outcomes. 3 HeartFlow’s FFR CT Analysis is covered by Medicare and for >99% of commercially insured lives.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

GEMMS

MARCH 7, 2024

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). Report 6 measures, including one Outcome or other High Priority measure for 12 months on at least 70% of eligible encounters to receive a score based on 2023 National Benchmarks.

Medicare 52

Medicare CMS Document Technology 52

Vector Remote

MARCH 9, 2023

RPM solutions are improving healthcare outcomes and helping patients lead healthier lives. With effective management and use, RPM can provide clinicians with the tools to improve patient outcomes and deliver better quality care. What is Cardiac Remote Patient Monitoring Software ?

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

DAIC

APRIL 24, 2024

CVD is especially prevalent in the Medicare-aged population, affecting more than 75 percent of those aged 60-79 and more than 90 percent of those aged 80 and over. About the Study The study evaluated engagement and clinical outcomes among age 65+ participants of an mHealth app-based CV risk self-management program.

Blood Pressure 116

Blood Pressure Cholesterol Technology Heart Attack 116

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

DECEMBER 8, 2023

The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy. The company recently announced it has received CMS approval for Medicare coverage during the DRAIN-HF pivotal trial.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

DAIC

DECEMBER 5, 2024

With this new funding, Cleerly will continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway. We’re proud to be a part of Cleerly’s journey. This is what good software can do in the world!"

Coronary Artery Disease 52

Coronary Artery Disease Medicare Technology Plaque 52

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. 10 , 11 , 12 , 13 As healthcare systems increasingly adopt value-based care models, extending monitoring beyond 48 hours can improve patient outcomes, reduce missed diagnoses, and help contain healthcare resource utilization. iRhythm Technologies, 2025.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , said Peter Altman , PhD., BioCardia’s President and Chief Executive Officer. “To

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

MARCH 7, 2024

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. We thank the FDA for its speedy review and approval of the important follow-on Phase III trial.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

DAIC

JANUARY 13, 2025

Additionally, the company announced that the Centers for Medicare & Medicaid Services (CMS) has granted Category B approval for the investigational device exemption (IDE) study, ensuring Medicare coverage for the device, related and routine items, and services for the ELITE-BTK trial. Commenting on the announcements, Christopher M.

Peripheral Arterial Disease 52

Peripheral Arterial Disease CMS Medicare Medicaid 52

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. 5 Bhatt, D.

CMS 52

CMS Blood Pressure Medicare Hypertension 52